Home » Topics » BioWorld Science

BioWorld Science
RSS

Synvisc introduced in U.S.

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Alza: Q3 1997 highlights

Nov. 20, 1997

Update on Prizm's novel Directin-based product pipeline

Nov. 20, 1997

Preliminary phase III data presented on celecoxib at arthritis symposium

Nov. 20, 1997

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

United Biomedical and California lab to collaborate on novel HIV therapeutic

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Insulin therapy found useful in patients with type II diabetes

Nov. 20, 1997

Effects of rPAF-AH in opossums with severe pancreatitis

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...